ARTICLE | Clinical News
rhBMP-2/ACS recombinant protein treatment regulatory update
June 25, 2001 7:00 AM UTC
The FDA did not approve a PMA application for Wyeth-Ayerst's rhBMP-2/ACS recombinant protein treatment applied to an Absorbable Collagen Sponge matrix (ACS) for long-bone fractures. AHP division Wyet...